Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Orchestra BioMed Holdings, Inc. (OBIO) had Revenue of $2.64M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.64M
Net Income	$-61.02M
Cost of Goods Sold	$0.20M
Gross Profit	$2.43M
Operating Expenses	$66.94M
Operating Income	$-64.30M
Non-Operating Income/Expense	$3.28M
Pre-Tax Income	$-61.02M
Normalized Pre-Tax Income	$-60.96M
Income after Taxes	$-61.02M
Income from Continuous Operations	$-61.02M
Consolidated Net Income/Loss	$-61.02M
Normalized Income after Taxes	$-60.96M
EBIT	$-64.30M
EBITDA	$-63.96M
Weighted-Average Shares Outstanding (Basic)	36.82M
Weighted-Average Shares Outstanding (Diluted)	36.82M
Earnings per Share (EPS) (Basic)	$-1.66
Earnings per Share (EPS) (Diluted)	$-1.66
Balance Sheet Financials
Current Assets	$69.17M
Property, Plant, and Equipment	$1.38M
Long-Term Assets	$7.00M
Total Assets	$76.17M
Current Liabilities	$16.21M
Long-Term Debt	$14.29M
Long-Term Liabilities	$27.01M
Total Liabilities	$43.22M
Common Equity	$32.96M
Tangible Shareholders Equity	$32.96M
Shareholders Equity	$32.96M
Common Shares Outstanding	38.19M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-50.56M
Cash Flow from Investing Activities	$13.09M
Cash Flow from Financial Activities	$29.17M
Beginning Cash	$30.56M
End Cash	$22.26M
Increase/Decrease in Cash	$-8.30M
Stock-Based Compensation	$10.62M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.27
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.43
Gross Margin	92.27%
Operating Margin	-2437.49%
EBIT Margin	-2437.49%
EBITDA Margin	-2424.64%
Pre-Tax Profit Margin	-2313.27%
Profit Margin	-2313.27%
Free Cash Flow	$-50.85M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.03
Inventory Turnover	1.18
Receiveable Turnover	28.67
Days Sales in Receivables	12.73
Return on Equity	-185.16%
Return on Tangible Equity	-185.16%
Return on Assets	-80.11%
Return on Investments	-129.15%
Book Value Per Share	$0.86
Free Cash Flow per Share	$-1.38
Operating Cash Flow per Share	$-1.37

Data from Zacks Investment Research, Inc.